35629-70-0Relevant articles and documents
Synthesis of 17beta-(2-amino-oxazol-4-yl)-steroids.
Rapi,Ginanneschi,Chelli
, p. 1999 - 2001 (1975)
-
Synthesis and biological evaluation of sulfonamidooxazoles and β-keto sulfones: Selective inhibitors of 11β-hydroxysteroid dehydrogenase type I
Xiang, Jason,Ipek, Manus,Suri, Vipin,Massefski, Walt,Pan, Ning,Ge, Ying,Tam, May,Xing, Yuzhe,Tobin, James F.,Xu, Xin,Tam, Steve
, p. 2865 - 2869 (2007/10/03)
The design, synthesis, and biological evaluation of arylsulfonamidooxazoles as 11β-HSD1 inhibitors and the serendipitous discovery of β-keto sulfones as potent 11β-HSD1 inhibitors are described here. These two classes of compounds are not active against 11β-HSD2 and therefore may have significant therapeutic potential for metabolic syndrome, type 2 diabetes and related metabolic dysfunctions.
Antianaphylactic agents. 1. 2-(Acylamino)oxazoles
Ross,Harrison,Jolley,Neville,Todd,Verge,Dawson,Sweatman
, p. 412 - 417 (2007/10/08)
The synthesis and biological properties of 35 2-(acylamino)oxazoles are described. The majority of the compounds inhibit the release of slow-reacting substance of anaphylaxis (SRS-A) in vitro from sensitized guinea pig chopped lung. In addition, several of the compounds inhibited the release of SRS-A from passively sensitized human chopped lung and protected guinea pigs from the effects of anaphylaxis in a modified Herxheimer test.